Does a von Willebrand factor (vWF) level of 0.93 rule out type 2 von Willebrand's disease with an antigen activity ratio of 0.7?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Von Willebrand Disease Type 2 Diagnosis with vWF 0.93 and Antigen Activity Ratio of 0.7

A von Willebrand factor (vWF) level of 0.93 does NOT rule out type 2 von Willebrand disease when the antigen activity ratio is 0.7, as type 2 VWD is primarily diagnosed by a low VWF:RCo/VWF:Ag ratio (<0.5-0.7), regardless of the absolute vWF level. 1

Understanding VWD Type 2 Diagnosis

Type 2 VWD is characterized by qualitative defects in vWF function rather than just quantitative deficiency. The key diagnostic features include:

  • VWF:RCo/VWF:Ag ratio: A ratio below 0.5-0.7 strongly suggests type 2 VWD, even when individual values appear normal 1, 2
  • Normal vWF levels: Type 2 VWD can present with normal vWF antigen levels (30-200 IU/dL) but functional defects 1
  • Multimer analysis: Different patterns distinguish between subtypes 2A, 2B, 2M, and 2N 3

Your Specific Case Analysis

With a vWF level of 0.93 (93%) and an antigen activity ratio of 0.7:

  • The vWF level is within normal range, which is common in type 2 VWD
  • The antigen activity ratio of 0.7 is at the borderline cutoff for diagnosing type 2 VWD
  • This pattern is most consistent with type 2M VWD, which often shows normal or near-normal multimer patterns but decreased VWF activity relative to antigen levels 3

Diagnostic Algorithm for Type 2 VWD

  1. Initial screening:

    • Assess VWF:Ag and VWF activity (VWF:RCo)
    • Calculate VWF:RCo/VWF:Ag ratio
  2. Interpretation:

    • Ratio >0.7: Type 2 VWD unlikely
    • Ratio 0.5-0.7: Borderline, consider type 2 VWD (especially 2M)
    • Ratio <0.5: Strong evidence for type 2 VWD
  3. Further testing for borderline cases:

    • VWF multimer analysis
    • Ristocetin-induced platelet aggregation (RIPA)
    • Collagen binding assay (VWF:CB)
    • Genetic testing for confirmation

Common Pitfalls in Diagnosis

  • Overreliance on absolute vWF levels: Type 2 VWD diagnosis depends on the activity-to-antigen ratio, not absolute levels 2
  • Stress-induced elevation: VWF is an acute phase reactant that can be falsely elevated during stress, masking underlying defects 1
  • Single testing: The American Academy of Pediatrics notes that VWF testing may need to be repeated up to 3 times for reliable results 1
  • Missing subtle variants: Type 2M VWD is frequently misdiagnosed as type 1 or 2A VWD 2

Conclusion for Clinical Decision Making

The doctor's statement that a vWF level of 0.93 makes type 2 VWD impossible is incorrect based on current guidelines. The antigen activity ratio of 0.7 places this case at the borderline for type 2 VWD diagnosis, most likely type 2M. Further specialized testing including multimer analysis and possibly genetic testing would be appropriate to confirm the diagnosis.

References

Guideline

Diagnosis and Management of von Willebrand Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Classification and characterization of hereditary types 2A, 2B, 2C, 2D, 2E, 2M, 2N, and 2U (unclassifiable) von Willebrand disease.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.